NASDAQ:NVOS Novo Integrated Sciences (NVOS) Stock Price, News & Analysis $0.0020 0.00 (0.00%) As of 10/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About Novo Integrated Sciences Stock (NASDAQ:NVOS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NVOS alerts:Sign Up Key Stats Today's Range$0.0020▼$0.002050-Day Range N/A52-Week Range$0.00▼$0.06Volume48 shsAverage Volume7,159 shsMarket Capitalization$39.46 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Novo Integrated Sciences, Inc. (NASDAQ: NVOS) is a healthcare company focused on providing multidisciplinary medical services and developing or commercializing healthcare-related products and technologies. Its business model is centered on integrated, patient-focused care delivered through affiliated and subsidiary operations. Through its Canadian healthcare operations, including Novo Healthnet Limited, the company has provided services such as primary care, physiotherapy, chiropractic care, massage therapy, acupuncture, occupational therapy and other allied-health treatments. Its healthcare services are designed to support preventative care, rehabilitation, chronic-condition management and general wellness. Novo Integrated Sciences has also pursued opportunities involving medical technology, telehealth and healthcare products intended to complement its clinical-services platform. The company’s operating history has primarily been associated with Canada, particularly Ontario, while it has explored broader geographic and commercial expansion. Robert Mattacchione has been identified in company filings and announcements as the company’s chairman and chief executive officer.AI Generated. May Contain Errors. Read More Receive NVOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVOS Stock News HeadlinesNovo Integrated Sciences Reports 2024 Fiscal Year Financial ResultsDecember 18, 2024 | businesswire.comNovo Integrated Sciences (NASDAQ:NVOS) Stock Quotes, Forecast and News SummarySeptember 4, 2024 | benzinga.comWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.October 16 at 1:00 AM | Brownstone Research (Ad)NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q3 2024July 19, 2024 | investorplace.comNovo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing ProgramJuly 19, 2024 | finance.yahoo.comNovo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial ResultsJuly 19, 2024 | finance.yahoo.comWhat's Going On With Novo Integrated Sciences Stock On Friday?July 19, 2024 | msn.comNovo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing ProgramJune 13, 2024 | businesswire.comSee More Headlines NVOS Stock Analysis - Frequently Asked Questions How have NVOS shares performed this year? Novo Integrated Sciences' stock was trading at $0.0027 at the start of the year. Since then, NVOS shares have decreased by 25.9% and is now trading at $0.0020. When did Novo Integrated Sciences' stock split? Shares of Novo Integrated Sciences reverse split on Tuesday, November 7th 2023.The 1-10 reverse split was announced on Tuesday, November 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Novo Integrated Sciences? Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Novo Integrated Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Integrated Sciences investors own include Tesla (TSLA), T2 Biosystems (TTOO), Workhorse Group (WKHS), Avalo Therapeutics (AVTX), Canopy Growth (CGC), Cybin (HELP) and SeaStar Medical (ICU). Company Calendar Today10/16/2026Fiscal Year End8/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolNASDAQ:NVOS CIK1138978 Webnovointegrated.com Phone(206) 617-9797FaxN/AEmployees115Year Founded2000Profitability EPS (Trailing Twelve Months)($0.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.17 million Net Margins-121.55% Pretax Margin-121.32% Return on Equity-93.07% Return on Assets-46.28% Debt Debt-to-Equity Ratio0.01 Current Ratio0.37 Quick Ratio0.30 Sales & Book Value Annual Sales$13.52 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.77 per share Price / Book0.00Miscellaneous Outstanding Shares19,730,000Free Float17,678,000Market Cap$39.46 thousand OptionableNot Optionable Beta5.83 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:NVOS) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Integrated Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Integrated Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
